Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Lamarca

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Medicina Clinica|April 7, 2015
[Beyond "data sharing"]Rosa Lamarca, Diego Herrera
Health and Quality of Life Outcomes|September 4, 2003
Classical Test Theory versus Rasch analysis for quality of life questionnaire reductionLuis Prieto, Jordi Alonso, Rosa Lamarca
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2006
The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoeaHeinz Letzel, Yves Mégard, Rosa Lamarca, et al.
Journal of Clinical Epidemiology|December 19, 2003
A changing relationship between disability and survival in the elderly population: differences by ageRosa Lamarca, Montserrat Ferrer, Per Kragh Andersen, et al.
Social Science & Medicine (1982)|August 4, 2006
Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditionsFrancesc Orfila, Montserrat Ferrer, Rosa Lamarca, et al.
COPD|May 10, 2016
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled StudiesJadwiga A Wedzicha, Alvar Agusti, Gavin Donaldson, et al.
Journal of Clinical Pharmacology|July 14, 2009
Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participantsJosep M Jansat, Rosa Lamarca, Gonzalo de Miquel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 13, 2023
Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance TherapyHelen Kathryn Reddel, Guy Brusselle, Rosa Lamarca, et al.
Respiratory Research|May 25, 2016
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studiesPaul W Jones, Nancy K Leidy, Asha Hareendran, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE StudyGary T Ferguson, Tor Skärby, Lars H Nordenmark, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Medicina Clinica|April 7, 2015
[Beyond "data sharing"]Rosa Lamarca, Diego Herrera
Health and Quality of Life Outcomes|September 4, 2003
Classical Test Theory versus Rasch analysis for quality of life questionnaire reductionLuis Prieto, Jordi Alonso, Rosa Lamarca
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2006
The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoeaHeinz Letzel, Yves Mégard, Rosa Lamarca, et al.
Journal of Clinical Epidemiology|December 19, 2003
A changing relationship between disability and survival in the elderly population: differences by ageRosa Lamarca, Montserrat Ferrer, Per Kragh Andersen, et al.
Social Science & Medicine (1982)|August 4, 2006
Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditionsFrancesc Orfila, Montserrat Ferrer, Rosa Lamarca, et al.
COPD|May 10, 2016
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled StudiesJadwiga A Wedzicha, Alvar Agusti, Gavin Donaldson, et al.
Journal of Clinical Pharmacology|July 14, 2009
Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participantsJosep M Jansat, Rosa Lamarca, Gonzalo de Miquel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 13, 2023
Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance TherapyHelen Kathryn Reddel, Guy Brusselle, Rosa Lamarca, et al.
Respiratory Research|May 25, 2016
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studiesPaul W Jones, Nancy K Leidy, Asha Hareendran, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE StudyGary T Ferguson, Tor Skärby, Lars H Nordenmark, et al.
Pageof 3